Post-Marketing Safety Study Following Long-Term Prophylactic OptivateTreatment in Subjects With Severe Haemophilia A

NCT01811875 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped Study no longer required as Optivate German license expired in Sep-2017.

Conditions

Haemophilia A

Interventions

BIOLOGICAL: Optivate 500IU

Sponsor

Bio Products Laboratory